Philippe Ledru

All filings by Philippe Ledru on record concern Aptose Biosciences Inc. Between 6 April 2022 and 24 May 2023, the trades on record add up to 3 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The record was last updated on 17 August 2023 with a transaction in Aptose Biosciences Inc. The median gap between a trade and its publication by SEC (Form 4) is 7 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.